Puma Biotechnology (PBYI) EBT Margin (2017 - 2026)
Puma Biotechnology's EBT Margin came in at 14.59% for Q2 2026, up 2.84 percentage points from 11.76% a year earlier and up 22.24 percentage points from the prior quarter.
Puma Biotechnology (PBYI) EBT Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Puma Biotechnology reported EBT Margin of 13.48%, down 4.28 percentage points year-over-year; for FY2025, it was 15.67%, up 5.21 percentage points from FY2024.
- EBT Margin has increased in each of the last eight years, with a five-year change of +42.23 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was 10.46% in FY2024 (+0.83 pp), 9.62% in FY2023 (+9.42 pp), 0.20% in FY2022 (+11.58 pp) and -11.38% in FY2021 (+15.18 pp).
- The five-year range for quarterly EBT Margin is -96.52% (Q3 2021) to 25.59% (Q3 2024).
- Year-over-year, EBT Margin increased in six of the last eight quarters, with an average year-over-year change of +4.68 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q3 2022 (a gain of 96.01 percentage points), and the weakest in Q3 2021 (a drop of 34.53 percentage points).
- Business Quant data shows PBYI's EBT Margin at -7.65% (Q1 2026), 22.67% (Q4 2025) and 16.97% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 14.59% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.59% |
| Mar 31, 2026 | -7.65% |
| Dec 31, 2025 | 22.67% |
| Sep 30, 2025 | 16.97% |
| Jun 30, 2025 | 11.76% |
| Mar 31, 2025 | 7.10% |
| Dec 31, 2024 | 20.72% |
| Sep 30, 2024 | 25.59% |
| Jun 30, 2024 | -8.82% |
| Mar 31, 2024 | -10.50% |
| Dec 31, 2023 | 17.74% |
| Sep 30, 2023 | 10.71% |
| Jun 30, 2023 | 4.24% |
| Mar 31, 2023 | 2.93% |
| Dec 31, 2022 | -8.09% |
| Sep 30, 2022 | -0.51% |
| Jun 30, 2022 | 15.84% |
| Mar 31, 2022 | -7.36% |
| Dec 31, 2021 | 8.01% |
| Sep 30, 2021 | -96.52% |
Puma Biotechnology EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();